Motor Function Performance in Individuals with RYR1-Related Myopathies

Witherspoon JW, Vuillerot C, Vasavada RP, Waite MR, Shelton M, Chrismer IC, Jain MS, Meilleur KG.
Muscle Nerve. 2019. 60(1),80-87.
Natural history study of 34 individuals with RYR1- related myopathy (RYR1-RM) during 6 months.
Motor deficits according to MFM-32 were primarily observed in the MFM-D1 (D1 mean = 71%) at baseline. RYR1-RM remained stable over 6 months.

PubMed link

Keywords : RYR1, GFT, MFM, Disease progression, Motor function

Articles in scientific journals

Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled phase 2 trial

Bertini E, Dessaud E, Mercuri E, Muntoni F, Kirschner J, Reid C, Lusakowska A, Comi GP, Cuisset JM, Abitbol JL, Scherrer B, Ducray PS, Buchbjerg J, Vianna E, van der Pol WL, Vuillerot C, Blaettler T, Fontoura P; Olesoxime SMA Phase 2 Study Investigators Lancet Neurol....

read more